Topotecan Hydrochloride Crystalline Forms Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current crystalline forms of topotecan hydrochloride, such as Form A, face challenges in stability and solvent removal, with varying water and chloride content stability and higher solvent residues, which affect their long-term purity and ease of drying.
Innovation Solution
Development of novel crystalline forms (Forms B to K) characterized by specific XRPD and FT-IR patterns, with Form D exhibiting enhanced stability, lower solvent residues, and easier solvent removal, achieved through controlled crystallization processes involving different solvents and pH conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional crystalline forms (Form A) are used, then the compound can be obtained through standard crystallization, but the stability is poor and solvent residues are high
Solution Approach 1:
The patent applies parameter changes by modifying crystallization conditions including pH levels, solvent types (acetone, ethyl acetate, isopropyl alcohol, toluene), temperature profiles, and drying conditions to transform the compound from unstable Form A with high solvent residues to stable Forms B-K with low solvent residues. Each crystalline form represents a specific set of optimized parameters that resolve the contradiction between stability and solvent content.
Solution Approach 2:
The patent utilizes phase transitions through controlled crystallization processes where the compound transitions from solution phase to solid crystalline phase under specific conditions. By controlling the phase transition parameters (solvent selection, cooling rates, pH adjustment), the patent achieves formation of stable crystalline forms with minimized solvent incorporation, directly addressing the stability-solvent residue contradiction.
2Ease of manufacture
If Form A is used, then the crystallization process is straightforward, but drying is difficult and time-consuming
Solution Approach 1:
The patent modifies manufacturing parameters by selecting crystallization solvents with appropriate volatility and solubility characteristics. Forms B-K are obtained using solvents like acetone, ethyl acetate, and toluene that facilitate easier removal compared to Form A, reducing drying time while maintaining ease of crystallization through optimized pH and temperature parameters.
Solution Approach 2:
The patent employs volatile solvents that can be easily removed through evaporation or drying, effectively using short-living solvent molecules that leave minimal residue. This approach allows straightforward crystallization followed by efficient solvent removal, resolving the contradiction between manufacturing ease and drying time.
3Ease of manufacture
If Form A is used, then the initial crystallization is simple, but long-term purity is compromised
Solution Approach 1:
The patent optimizes crystallization parameters including pH control, solvent selection, and temperature profiles to produce Forms B-K that exhibit superior long-term stability and purity retention. These parameter optimizations ensure that the crystalline structure resists degradation and solvent re-absorption over time, maintaining manufacturing precision while preserving crystallization simplicity.
Solution Approach 2:
The patent implements quality feedback through characterization techniques (XRPD, FT-IR, HPLC) to verify that the crystallized forms meet stability and purity specifications. This feedback mechanism ensures that Forms B-K are consistently produced with the desired properties, maintaining long-term purity while keeping the crystallization process straightforward through validated parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel crystalline forms, particularly Form D, demonstrate improved stability and reduced solvent residues, maintaining high purity over time and facilitating efficient drying, outperforming existing forms like Form A in stability and processing.
Implementation Method 1
crystallization processes involving different solvents and pH conditions
Data Source
AI summary
Novel crystalline forms of topotecan hydrochloride and processes of making the same are disclosed.